PHASQ — PhaseBio Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$3.73m
- $10.83m
U.S. STOCKS ON THE MOVE-Socket Mobile Inc, Iterum Therapeutics, American Express
U.S. STOCKS ON THE MOVE-Intel, Mattel Inc, American Express
U.S. STOCKS ON THE MOVE-Socket Mobile, Gilead, Intel
PhaseBio: Falls after discontinuing COVID-19 drug trial
Brief: PhaseBio Reports VANGARD trial discontinued due to COVID-19 treatment landscape
Brief: PhaseBio Doses First Patients In Canada As Part Of REVERSE-IT Global Phase 3 Trial Of Bentracimab
U.S. RESEARCH ROUNDUP- Cactus, Starbucks, Williams-Sonoma
Brief: PhaseBio Pharmaceuticals Reports QTRLY Loss Per Share Of $0.98
PhaseBio rises on starting mid-stage trial for COVID-19 drug
Brief: PhaseBio Doses First Patient In Vangard Phase 2 Clinical Trial
U.S. RESEARCH ROUNDUP- Apache, Bloomin' Brands, MEI pharma
PhaseBio Pharma: Surges on go-ahead for COVID-19 drug trial
Brief: Phasebio Launches Clinical Trial To Evaluate Pb1046 As A Treatment For Hospitalized Covid-19 Patients
Brief: PhaseBio Pharmaceuticals Q1 Loss Per Share $0.52
U.S. RESEARCH ROUNDUP- Plantronics, Stericycle, Thomson Reuters
Brief: Phasebio Pharmaceuticals Q4 Loss Per Share $0.39
Brief: Phasebio Appoints Alex Sapir To Board Of Directors
Brief: Phasebio Announces European Regulatory Update For Pb2452
Brief: Phasebio Announces Case Study Highlighting Pb1046 Hemodynamic Data